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1. Introduction
Legumes are important for the diet of a significant part of the world´s population; they are a
good source of protein, carbohydrates, minerals and B-complex vitamins. In this sense, the
soybean is an important legume because it has a high protein (35-48%) with a nutritionally
balanced amino acid profileso their products are commonly used as a source of vegetable
protein worldwide and a great proportion of high-quality oil (15-22%)[1].
The accessible price and stable supply are favourable factors for legumes to emerge as an
important source of protein for human food [2]. However, the nutritional value of soybeans
is lower than expected due to the presence of various non-nutritive compounds that hinder
or inhibit the uptake of nutrients and produce adverse physiological and biochemical effects
in humans and animals; since these could be toxic in some cases, they are referred as anti-
nutritional factors [3, 4].
Recently it has been found that legumes, in the appropriate proportion, may have a benefi‐
cial role for health. It seems clear that, in many cases, the same interaction that causes le‐
gumes to be considered as anti-nutrients is responsible for its beneficial effects.
Thereby,these compounds are called non-nutritional compounds or nutritionally bioactive
factors, because while they lack nutritive value, are not always harmful [5]. Available data
indicate that the balance between harmful and beneficial effects of these compounds is a
function of concentration, exposure time and interaction with other dietary components.
However, the threshold concentration at which the beneficial and harmful effects occur has
not been evaluated in most cases [6].Moreover, they are compounds that do not appear
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equally in all legumes, and their physiological effects in humans and other animals are dif‐
ferent as well [7, 8].
These compounds have an important role in secondary metabolism of legumes, as reserve
compounds for the biosynthesis of endogenous compounds, which accumulate in seeds and
are used during the germination process, and as mechanisms of defense against bacteria, vi‐
ruses, fungi, insects and animals [9].
From a biochemical point of view, these compounds have diverse nature. They may be pro‐
teins (protease inhibitors, α-amylase inhibitors and lectins), carbohydrates (α-galactosides,
vicine, convicine, saponins), non-protein amino acids (L-DOPA, β-ODAP), polyphenols
(condensed tannins, isoflavones), alkaloids, inositol phosphates, etc., so their extraction and
quantification methodology is very specific. In soybeans, the non-nutritional factors are
mainly; inositol phosphates, saponins, protease inhibitors, isoflavones, lectins, oligosacchar‐
ides and taninis[10, 11].
1.1. Phytic acid and inositol phosphates
Phytic acid (myo-Inositol hexakisphosphate or 1, 2, 3, 4, 5, 6-hexakis dihydrogen phosphate
myo-Inositol), also abbreviated as InsP6 or IP6, is the main form of storage of phosphorus
and inositol in seeds of cereals, legumes and oilseeds. However for humans and monogas‐
tric animals phosphorus is not available in that form, because these are not provided with
sufficient activity of endogenous phosphatases (phytases) that are capable of releasing the
phosphate group from phytic acid or inositol phosphates lighter phosphorylated [12].
This molecule is formed from the esterification of phosphate groups to each of the six hy‐
droxyl groups in a molecule known as myo-Inositol (Figure 1). Usually, it represents 65 to
85% of total phosphorus in seeds while forming insoluble salts with mono and divalent cati‐
ons. By releasing H+ ions from the phosphate groups, allows the molecule to interact with
the ions Mn2+, Fe2+, Zn2+ and K+ to produce the corresponding salts, which are known as phy‐
tates. The name phytin has been used to designate a mixture of salts with Ca2+ and Mg2+.
Phytates and phytins usually bind to proteins in the protein bodies, the latter are mem‐
brane-limited structures where storage proteins are deposited. Salts of phytic acid are accu‐
mulated in seeds during the maturation period and are distributed uniformly in the
cotyledons and embryonic axis in legumes [13, 14].
Figure 1. A) Chemical structure of myo-Inositol, B) Phytic acid structure (P) = H2PO4 [15]
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In the soybean (Glycine max) phytic acid is uniformly distributed in the cotyledons, in the
same way as in most legumes, probably as a soluble potassium phytate, which constitutes
approximately 1.5% of the total weight of the cotyledon. One gram of soybeans contains
about 9.2-16.7 mg of phytate, which represents 57% of organic phosphorus and 70% of total
phosphorus [16, 17].
1.1.1. Synthesis and Function
Phytic acid is sythesized from 1D-myo-Inositol 3-phosphate (Ins3P1); in turn, the latter is
formed from D-glucose-6-phosphate by action of synthase Ins3P1, and from myo-Inositol by
action of myo-Inositol kinase; this reaction represents the first step in the metabolism of ino‐
sitol and in the phytic acid biosynthesis. Subsequently, the phosphatidylinositol kinases cat‐
alyze the gradual phosphorylation of Ins3P1 to produce myo-Inositol di-, tri-, tetra-, penta-
and hexaphosphate (Figure 2) [14, 18, 19].
During germination, phosphorus and cations are released from phytates by the increased ac‐
tivity of an enzyme called phytase, then, they become available for use during the seedling
growth. The enzyme phytase (myo-Inositol-hexaquisfosfatophosphohydrolase) is capable of
sequentially hydrolyzing phytic acid to myo-Inositol, which produces intermediate prod‐
ucts with a lower number of phosphate ester groups (IP5, IP4, IP3, and possibly di- and
mono- phosphateinositols) and inorganic phosphate [20, 21].
Figure 2. Biosynthesis of phytic acid [14].
A clear role of phytic acid in the seed tissues metabolism is the storage and recovery of
phosphorus, minerals, and myo-Inositol during germination and growth [22]. Another
physiological functions of phytic acid in plants, is the inhibition of the metabolism, since, by
binding to multivalent cations required for cellular processes, the metabolism is slower, so it
could be a latency-inducing molecule. Furthermore, the antioxidant capacity of phytic acid
increases the time of seed latency, as it prevents lipid peroxidation [18, 23].
As well, phytates and also less-phosphorylated forms of phytic acid regulate diverse cel‐
lular  functions such as  DNA repair,  chromatin remodelling,  endocytosis,  nuclear  export
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of  mRNA, and is  an important  hormonal  marker  for  the development of  seedlings and
seeds [24-28].
Less-phosphorylated molecules of myo-Inositol are presentin free form in nature, in small
amounts, as transient intermediates in biochemical reactions. The mono-, bi-, tri- myo-Inosi‐
tol phosphates are important components of a group of phospholipids, known as phosphoi‐
nositides, which are present in many plants and animal tissues [18]. Raboy (2009),reported a
very detailed description of the synthesis and metabolism of phytic acid and myo-Inositol
phosphates in plants (Figure 3).
Figure 3. Pathways in plant biology that utilize myo-Inositol [29].
1.1.2. Bioavailability of minerals
Most studies on the interaction between phytic acid/inositol phosphates and minerals reveal
the existence of an inverse relationship between the absorption of these micronutrients and
inositol phosphates, although there are substantial differences in individual behaviour of
each mineral element [16].
The interaction of phytic acid with minerals and other nutrients is pH-dependent [30], since
the degree of protonation of the phosphate groups is a function of pH [31]. The molecule
works in a wide region of pH as a highly negatively-charged ion, so its presence in the diet
has an adverse impact on the bioavailability of mineral monovalent, divalent and trivalent
ions, such as Zn2+, Fe2+ / Fe3+, Ca2+, Mg2+, Mn2+ and Cu2+[32-34]; these complexes are more
soluble at low or acid pH and insoluble at high or basic pH [35].
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Another important aspect to be considered is that the interaction of phytic acid with miner‐
als is due to its several phosphate groups, thereby, minerals may bind to one, two, or more
phosphate groups of one, two or more phytic acid molecules [36]. Other studies have shown
that the inhibitory effect of the absorption of InsP depends on the degree of phosphorylation
of inositol, when it is high (5 or 6 phosphates) the absorption of Ca and Zn is significantly
inhibited, however at lower levels of phosphorylation this effect is not observed [34].
The solubility of the complexes formed depends also on the InsP-mineral ratio; for instance,
the solubility of the InsP-Ca complex, is extremely low in 1/8 ratios, but other ratios show
higher solubility [37]. The complexes hexa-, penta-, tetra- and tri- Ca are insoluble, while
complexes mono- and di- Ca are soluble [38]. Nevertheless, the absorption of Cafrom solu‐
ble complexes InsP-Ca is very low, because these complexes do not undergo passive trans‐
port in gut due to the high electric charge they have [39].
The inositol phosphates directly or indirectly interact with various minerals in the diet to re‐
duce their bioavailability, in this context, the synergistic effect of the secondary cations
(Ca2+) has been widely demonstrated. Two cations may, when present at the same time, act
together to increase the amount of insoluble precipitate in salt form, i. e. a mineral has a
higher affinity for certain complex (InsP-mineral) which generates more insoluble salts[40].
For instance, the phosphate inositol bound to Ca shows higher affinity to Zn, which decreas‐
es its reabsorption [41].
1.1.3. Bioavailability of proteins
The degree of interaction between phytic acid (and its phosphate inositols) and depends on
the protein, net charge, conformation and interactions with minerals at a given pH.At low
pH, below the isoelectric point of proteins, phytic acid phosphate esters bind to the cationic
group of basic amino acids, for example, arginine, histidine and lysine, may form InsP-pro‐
tein complexes.
At a pH above the isoelectric point of proteins, since the charge of proteins as well as that of
the phytic acid is negative, the interaction would be impossible, however, interaction occurs
through the formation of complexes with divalent such as Ca2+ or Mg2+. This binding takes
place via the formation of ionized carboxyl groups and the deprotonated imidazole group of
histidine, which requires a minimum concentration of these cations to maintain these com‐
plexes. At this pH, some binary complexes may exist because lisyl and arginyl residues of
the proteins are still positively charged. At high pH the interaction between proteins and
phytic acid decreases, arginyl and lysyl groups lose their charge, and therefore its ability to
form binary complexes [36]; as well, they may form complexes such as protein-InsPand pro‐
tein-mineral-InsP(Figure 4), which reduces their bioavailability.Such complexes may affect
the protein structure, which may decrease the enzyme activity, function, solubility, absorp‐
tion and protein digestibility [16, 36]. Particularly, the ability to inhibit proteolytic(pepsin,
trypsin, chymotrypsin), amylolytic (amylase) and lipolytic (lipase) enzymes, is responsible
of their anti-nutritional properties. This inhibition may be due to the nonspecific nature of
InsP-protein interactions and the chelation of calcium ions, which are essential for the activi‐
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ty of trypsin and α-amylase [16]. Furthermore, phytic acid can also bind to starch, either di‐
rectly via hydrogen bonds or indirectly through the proteins to which it is associated [42].
Figure 4. InsPinteractions with minerals, proteins and starch [36].
1.1.4. Pharmacological properties
In vivo and in vitro studies have shown that phytic acid (InsP6)has prevention and therapeu‐
tic properties against cancer. Several mechanisms have been suggested to explain its anti-
carcinogenic effect:
a. Experiments have shown that this compound induces apoptosis in cancer cells, causes
differentiation of malignant cells and its reversion to normal phenotype, and increases
the activity of natural killer cells of the immune system. In addition, IP3 and IP4 com‐
pounds have an important role in cellular signal transduction, regulating functions, cell
growth and differentiation [43].
b. A second way in which phytic acid reduces the risk of cancer, is by chelation of Fe3+ and
the suppression of the formation of radicals (∙OH), which also originates antioxidant
properties. Fe3+ is an effective catalyst for many biological functions, in which this ion is
reduced to Fe2+. The oxidation of Fe2+to Fe3+ leads to the formation of O2-• that spontane‐
ously generates O2 and H2O2. The Fenton's reagent (Fe2+ + H2O2) quickly generates ∙OH,
a highly-reactive oxyrradical which indiscriminately attacks most of the biomolecules.
By blocking the redox cycle of Fe, which is necessary in many oxidation reactions, the
lipid peroxidation and DNA damage are inhibited [ 37 , 44 ].
c. Zn is involved in DNA synthesis and cell proliferation as a cofactor for many enzymes
like thymidine kinase. So, by binding to Zn2+, the phytic acid indirectly reduces cell pro‐
liferation [45].
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d. Phytic acid can reduce the starch digestibility and cause low absorption, so that starch
remains available in the colon to be fermented by bacteria, producing short chain fatty
acids, which have protective activity against cancer [46].
Phytic acid can retard the digestion and absorption of starch in several ways: by direct bind‐
ing to the polysaccharide, by its binding to the α-amylase, or by chelation of Ca2+ needed for
activation of α-amylase. Through these mechanisms a delay occurs in the glycemic response,
therefore, due to lower blood glucose, insulin is required in less amount and this reduces the
risk of diabetes [47].
Respect to prevention of kidney stones and treatment of hypercalciuria, experimental evi‐
dences demonstrate that di- and tri- inositol phosphates (InsP2 and InsP3), are effective to
prevent the formation of hydroxyapatite crystals in vitro, which act as the core for the forma‐
tion of some kidney stones [24].
At levels from 0.2 to 9% of phytic acid in diet, the plasmatic levels of cholesterol and trigly‐
cerides are significantly reduced [48]. This seems to be related with the capability of phytic
acid to be bound to Zn, which reduces the serum levels of Zn and the Zn/Cu ratio, since
high values of this ratio tend to increase the risk of cardiovascular diseases, for instance, hy‐
percholesterolemia [42].
1.2. Saponins
Saponins (Figure 5) are a big group of glycosides which are known by their surfactant prop‐
erties and are widely distributed in green plants [49] .The name ‘saponin’ derives from the
Latin word sapo which means soap, due to their property of generating foam in agitated
aqueous solutions [50]. These substances are amphiphilic glycosides, wherein the polar con‐
stituents are sugars (pentoses, hexoses or uronic acids) that are covalently linked to a non-
polar group, which consists of an aglycone, called sapogenin, which can be either steroidal
or triterpenoid. This combination of polar and nonpolar components in their molecular
structure explains their surfactant property in aqueous solutions [51].
As mentioned above, the saponins are secondary metabolites that can be classified into two
groups based on the nature of the aglycone skeleton. The first group consists of steroidal
saponins, which are present almost exclusively in monocotyledons angiosperms. The second
group is composed of triterpenoidsaponins, which occur mainly in dicototyledonous flower‐
ing plants [52]. Steroidal saponins comprise a steroidal aglycone, a spirostane skeleton of 27
carbons (C27), which generally comprises a six-ring structure. In some cases, the hydroxyl
group at position 26 is used to form a glycosidic bond, so that the structure of the aglycone
becomes a pentacyclic structure; this structure is known as furostano skeleton. The triterpe‐
noidsaponins have an aglycone with a backbone of 30 carbons (C30), which form a pentacy‐
clic structure (Figure 5).
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Figure 5. Skeletons ofaglycone: (A) steroidal spirostane, (B) steroidal furostane (C) triterpenoid. R = sugar residue.
It has been identified that soy contains saponins with triterpenoid-type aglycones, this kind
of aglycones are subdivided into five major groups; soysapogenol A, B, C, D and E (Figure
6), and their glycosides are correspondingly called as saponins of group A, group B, and so
on[53, 54].From this classification, four aglycones (soysapogenol A, B, C and E) [55]were iso‐
lated after hydrolisis of soy saponins, specifically five saponins were identified 5 with two
distinct types of aglycones: soysapogenin I (the main component), soysapogenins II and III,
which contain soysapogenol B, and soysaponins A1, A2 and A3, which contain soysapoge‐
nol A[55].The saponins containing soyasapogenol C and E have not been found in soybeans,
so these aglycones could be formed as a product during the hydrolysis of saponins[56].An‐
other study reported the isolation and characterization of soysaponin IV. The type of sugars
attached to the aglycones found in soybeans have been identified as rhamnose, galactose,
glucose, arabinose, xylose and glucuronic acid [55].
Figure 6. Groups of soyasapogenols (Oakenfull, 1981).
The total content of saponins in the hypocotyl fraction of soybeans, where acetyl-soyasapo‐
nins A1 and A4, mainly, are syntesized, is approximately 0.62 to 6.16%[57]. Other works
have reported 5-6% saponin content in soybeans [58]. Lower values, approximately 0.6%,
have been reported as well [59].
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1.2.1. Synthesis and Function
The capability to synthesize saponins is widespread among plants belonging to the Magno‐
liophyta division, which includes both dicotyledons and monocotyledons. However, most of
saponin-producing species are within dicotyledonous plants. The biological function of sap‐
onins is not completely understood. They are usually considered as a part of the defense
system of the plant, due to their antimicrobial, fungicide, allelopathic, insecticide and mol‐
luscicide activities [60]. The synthesized saponins are accumulated during the regular
growth of plants. Nonetheless, their accumulation is influenced by several environmental
factors such as bioavailability of nutrients and water, solar radiation or a combination of
them[61]. Some studies on soy have shown a variation in the content of saponins in soy‐
beans with different degrees of maturity, however, the nature of this variation is not suffi‐
cient to influence on the saponindistribution in different varieties [57]. Little is known about
the enzymes and biochemical pathways involved in the biosynthesis of saponins in plants
[54]. However, two key aspects have been suggested for biosynthesis: the first one is the cyc‐
lization of the 2,3-oxidoscualene thought the isoprenoid pathway, which is a starting point
for the biosynthesis of the sapogenin, and the second one is the glycosylation of sapogenins.
1.2.2. Membranolytic activity
Saponins have the ability to cleavege the erythrocytes. This hemolytic property is generally
attributed to the interaction between saponins and sterols in the erythrocyte membrane. As
a result, the membrane is broken, which causes an increase in its permeability and the con‐
sequent loss of hemoglobin. It has been investigated the effect of saponins in the membrane
structure through human erythrocyte hemolysis[5, 62]. The results indicated that the frac‐
ture in the erythrocyte membrane was not closed again, so that the damage in the lipid bi‐
layer is irreversible. However, this toxic property is difficult to occur in vivo, since there is
evidence that no complications are detected when saponins are ingested orally, which re‐
duces his hemolytic capability to in vitro studies [63]. The saponins have little anti-nutrition‐
al activity, given no damage is produced in humans when they are consumed in the
amounts regularly found after food processing. However, high concentrations of saponins
are also capable of breaking the membrane of other cells such as those of the intestinal mu‐
cosa, which modifies the cell membrane permeability, and then affects the active transport
and the absorption of nutrients[45].
This ability to affect the cell membrane, depends on the structural characteristics of the sapo‐
nins, i. e. the structure of the aglycone, the number of sugars in the side chains and the side
chains length [64]. In Figure 7, the interaction of saponins with cell membranes is schemati‐
cally shown.
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Figure 7. Schematic models of the molecular mechanisms of saponin activities towards membranes [65]Saponins in‐
tegrate with their hydrophobic part (sapogenin) into the membrane. Within the membrane they form complexes with
sterols, which subsequently, driven by interaction of their extra-membranous orientated saccharide residues, accumu‐
late into plaques. Sterical interference of these saccharide moieties causes membrane curvature subsequently leading
to (A) pore formation in the membrane [66] or (B) hemitubular protuberances resulting in sterol extraction via vesicu‐
lation[67]. Alternatively, after membrane integration saponins may migrate towards sphingolipid/sterol enriched
membrane domains (C) prior to complex formation with the incorporated sterols, thereby interfering with specific do‐
main functionalities [68]. Similarly to (B), accumulation of saponins in confined membrane domains has further been
suggested to cause deconstructive membrane curvature in a dose-dependent manner.
1.2.3. Pharmacological properties
Many studies highlight the pharmaceutical properties of the soybean saponins, among
which the anti-carcinogenic activity is mentioned, given by the membranolyticactivity these
molecules have shown in human cells of colon carcinoma[69, 70]. Other studies have dem‐
onstrated hypocholesterolemic activity due to depletion of body cholesterol by preventing
its reabsorption, thus increasing its excretion. Soluble fibers in legumes are known to in‐
crease the viscosity of gastric and intestinal contents, and may be one of the factors responsi‐
ble for the lowering of cholesterol levels [71, 72]. Studies on health benefits of saponins
suggest their hepatoprotective activity, but these studies are limited to cell culture and few
animal studies. Studies on rats have shown soybean saponin to have an anabolic effect on
bone components, suggesting its role as a nutritional factor in the prevention of osteoporosis
[73]. Another activity that has been reported is anti-mutagenicity in breast cells [74].
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1.3. Inhibitors of trypsin
Protease inhibitors are proteins widely distributed in the plant kingdom, have the ability to
inhibit the proteolytic activity of digestive enzymes such as serine-proteases (trypsin and
chymotrypsin) which are characteristic of the gastrointestinal tract of animals, though also
may inhibit endogenous proteases and enzymes of bacteria, fungi and insects. These serine-
protease inhibitors are proteins that form very stable complexes with digestive enzymes,
which preventtheir catalytic activity [75].
Protease inhibitors have been classified into several families based on homology in the se‐
quence of amino acids in the inhibitory sites. The molecular structure of the inhibitor affects
both the force and the specificity of the inhibitor. The two main families of protease inhibi‐
tors found in legumes are the Kunitz inhibitor and the Bowman-Birk inhibitor, so named af‐
ter its isolation [2, 51]. In the latter case, the characterization was carried out by Birk, [ 76 ],
so this name was added.
Both types of proteases are found in soybeans (Glycine max); in other legume seeds, such as
beans (Phaseolus vulgaris) and lentil (Lens culinaris), protease inhibitors have been character‐
ized as members of the Bowman-Birk family. Both inhibitors are water soluble proteins (al‐
bumin) and constitute from 0.2 to 2% of total soluble protein of legumes [75, 77], particularly
soybeans havereported 50 trypsin inhibitor units / mg of dry sample [78].
1.3.1. Kunitztype inhibitor
The first protease inhibitor to be isolated and characterized was the Kunitz inhibitor. It has a
MW between 18 and 24 kDa and contains between 170 and 200 amino acid residues. These
inhibitors have one head, i. e., one molecule of inhibitor inactivates one molecule of trypsin.
It is a competitive inhibitor, binds to the active sites of trypsin in the same way the substrate
of the enzyme does, resulting in the hydrolysis of peptide bonds between amino acids of the
reactive site of the inhibitor or the substrate (Figure 8).
Figure 8. A) Primary structure of the Kunitz inhibitor from soybean [79]. Disulphide bonds are shown in black, B)Tridi‐
mentional structure Kunitz inhibitor from soybean [79].
Inhibitors differ from the substrate protein in the reactive site residues, which are linked via
disulphide bonds. After hydrolysis, the modified inhibitor maintains the same conforma‐
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tion, due to the disulphide bonds. This generates a stable enzyme-inhibitor complex. This
type of inhibitors are generally absent in seeds of Phaseolus, Pisum, Vigna unguiculata and
Glycine max [80].
1.3.2. Bowman-Birk type inhibitor
These inhibitors are low molecular weight polypeptides (7 to 9 kDa) containing 60 to 85 ami‐
no acid residues (Figure 9). They have several disulphide bonds which make them stable to
heat, acids and bases. These inhibitors have two heads (two separate sites of inhibition) and
are competitive inhibitors. They can simultaneously and independently inhibit two en‐
zymes, thus, there are trypsin/trypsin are trypsin/chymotrypsin inhibitors [74,77].
Figure 9. A) Primary structure of Bowman-Birk type inhibitor from soybean(Odani y Ikenaka, 1973). Disulphide bond‐
sand active sites for trypsin (Lys16-Ser17) and chymotrypsin (Leu44-Ser45) are shown in black B) Tridimentional struc‐
ture Bowman-Birk inhibitor from soybean [81]
An example of this type of inhibitor is the Bowman-Birk inhibitor from soybeans, which is
constituted by a polypeptide chain of 71 amino acids, containing seven disulphide bonds. It
has a MW of 8 kDa and is called dual head inhibitor because it has independent binding
sites for trypsin and chymotrypsin, so that the active site for trypsin is Lys16-Ser17, whereas
for chymotrypsin is Leu44-Ser45 [82, 83].
1.3.3. Synthesis and Function
Protease inhibitors have a regulatory function; they are involved the in proteolytic self-regu‐
lation process of the protein deposited in the protein bodies before and during the seed ger‐
mination by inhibiting endogenous proteases. They also participate as protective agents
against insects and microorganisms[76].
1.3.4. Anti-nutritional properties
Protease inhibitors ingested within legumes have adverse effects in animals. First, these
compounds form inactive complexes with trypsin/chymotrypsin, so that the levels of these
free digestive enzymes are reduced, thus making difficult proteolysis and amino acid ab‐
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sorption. In addition, these enzyme-inhibitor complexes, which are rich in sulfur amino
acids, are excreted.
Finally, these inhibitors cause hypertrophy/hyperplasia of the pancreas due to chronic hy‐
persecretion of pancreatic enzymes [trypsin and chymotrypsin), which leads to deviation of
the sulfur amino acids that were used to synthesize tissue proteins to the synthesis of these
enzymes [84]. All this derives in reduction of the amount of essential amino acids, which in‐
hibits animal growth and exacerbates an already critical situation with respect to the protein
of legumes which is deficient in sulfur amino acids [3, 84-87].
The mechanism by which inhibitors of proteases stimulate pancreatic secretion is not entire‐
ly clear. There is a theory about this secretion would be regulated by a negative feedback
mechanism, so that,  when the content of trypsin/chymotrypsin in duodenum is reduced
below a  certain  level,  the  endocrine  cells  of  the  duodenal  mucosa  release  the  hormone
cholecystokinin, prompting the pancreas to synthesize more serine-proteases (Figure 20).
The reduced levels of trypsin and chymotrypsin are produced when the protease inhibi‐
tors ingested reach the duodenum and bind to these digestive enzymes by forming com‐
plexes.  Although this does not seem to be the only mechanism by which the pancreatic
secretion is activated.
Recent studies have demonstrated that both states of protease inhibitors, free and enzyme-
inhibitor complexes, bind to the duodenal mucosa and stimulate the release of cholecystoki‐
nin, thus increasing the pancreatic secretion of serine proteases [84, 88]. The action of the
trypsin inhibitors on the human organism is not totally understood, since human trypsin
has two forms: cationic, which is the main component of pancreatic juice and is weakly in‐
hibited; and anionic, comprising about 10 to 20% of the total trypsin, which is completely
inhibited [82, 84].
1.3.5. Pharmacological properties
Since the Bowman-Birk type inhibitors are proteins with a high amount of cysteine , these
inhibitors make an important contribution to the content of sulfur amino acids, thus increas‐
ing the nutritional value of legumes[85, 89]. The Bowman-Birk inhibitor from soybeans as
well as their counterparts present in other legumes, are involved in the prevention and treat‐
ment of cancer (colon, breast, liver, lung, prostate, etc.) by inhibiting chymotrypsin. One
mechanism through which these compounds can prevent carcinogenesis is by reducing the
protein digestibility and the bioavailability of amino acids such as leucine, phenylalanine or
tyrosine, which are necessary for the development of cancer cells [90-92].
1.4. Isoflavones
Isoflavones are widely distributed in the plant kingdom, mainly in plants of the legume family,
being soybeans the source with the highest content of these components [93]. Isoflavones are
oxygen heterocycles containing a 3-phenylchroman skeleton that is hydroxylated at 40 and 7
positions (Figura 10) [94]. Based on the substitution pattern on carbons and 6, three aglycon
forms of isoflavones commonly found in soybeans are daidzein, genistein, and glycitein. These
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three isoflavones can also exist in conjugated forms with glucose (daidzin, geinstin, glyci‐
tin), malonylglucose (malonyldaidzin, malonylgeinstin, malonylglycitin), and acetylglucose
(acetyldaidzin, acetylgeinstin,  acetylglycitin) units.  Thus 12 free and conjugated forms of
isoflavones have been isolated from different soybean samples (Table 1) [95].
Figure 10. Chemical structureof an isoflavone [95].
Name R1 R2 R3
Daidzein H H H
Glycitein H OCH3 H
Genistein OH H H
Daidzin H H Glu
Glycitin H OCH3 Glu
Genistin OH H Glu
Acetyldaidzin H H Glu-COCH3
Acetylglycitin H OCH3 Glu-COCH3
Acetylgenistin OH H Glu-COCH3
Malonyldaidzin H H Glu-COCH2COOH
Malonylglycitin H OCH3 Glu-COCH2COOH
Table 1. Chemical structures of 12 isoflavones isolated from soybeans [95].
1.4.1. Synthesis and Function
The variation of the concentration of isoflavones in soybeans is mainly due to the soybean
variety, environment, location and growing conditions, such as year, area and temperature,
post-harvest storage and the methodology used to determine this concentration [95]. The
content of isoflavones in soybeans ranks 1.2 to 2.4 mg of total isoflavones per gram of sam‐
ple [96], distributed in different concentrations in the tissues of the seed, being higher in the
embryo than in the endosperm [97].
Soybean - Bio-Active Compounds400
In plants, these compounds play several roles, such as protection against UV light and phy‐
topathogens, signal transduction during nodulation, attraction of pollinator animals and de‐
fense against insects and herbivores[98].
1.4.2. Pharmacological properties
The enriched extracts of isoflavones have been evaluated for prevention of a wide range of
health problems associated with cardiovascular diseases, osteoporosis and breast cancer,
prostate and colon [99]. Furthermore, soy isoflavones have a structure very similar to a phe‐
nolic estrogen known as phytoestrogen, so that these compounds have been used as a natu‐
ral alternative for postmenopausal therapy [100].
1.5. Lectins
In soybeans, a class of proteins called lectins or phytohemagglutinins is present. These com‐
pounds can be defined as proteins or glycoproteins of non-immune origin, which can rever‐
sibly bind to specific sugar segments through hydrogen bonds and Van Der Waals
interactions, with one or more binding sites per subunit [101]. Lectins are tetrameric pro‐
teins composed of two different types of subunits: E-type subunit (MW = 34 kDa) and L-
type subunit (32 kDa). The first one has the characteristic of binding to erythrocytes, while
the second one to lymphocytes[102].Therefore, it is possible to find 5 combinations of these
four subunits, i. e. 5 isoforms, as follows: E4, E3L, E2L2, EL3, and L4. Soybean seeds show he‐
magglutinating activity at 2400 mg per mg of dry sample [78].
The name lectin [from Latin legere, which means to choose or to select), was adopted by
Boyd for many years to emphasize the caability of some lectins to bind specifically to cells of
the ABO blood groups [103]. Currently the name lectinis preferred over the haemagglutinin
one and is widely used to denote all vegetable proteins that possess at least one non-catalyt‐
ic domain, which binds reversibly to a specific mono- or oligosaccharide [104].
According to the overall structure of the plant lectins, these are subdivided into four main
classes: Merolectins which are proteins having a single carbohydrate-binding domain; Holo‐
lectins, comprising all lectins having di- or multivalent carbohydrate-binding sites; Chimer‐
olectins, proteins consisting of one or more carbohydrate-binding domain(s) plus an
additional catalytic or another biological activity dependent on a distinct domain other than
the carbohydrate- binding site; and Superlectins which also possess at least two carbohy‐
drate-binding domains but differ from the hololectins because their sites are able to recog‐
nise structurally unrelated sugars [105].
Lectins can be divided according to the monosaccharide for which they show the highest af‐
finity: D-mannose/D-glucose, D-galactose/N-acetyl-D-galactosamine, L-fucose and N-acetyl‐
glucosamineacid [106]. Thus depending on the specificity toward a given monosaccharide
the lectin will selectively bind to one of these above sugars which are typical constituents of
eukaryotic cell surfaces [101].
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1.5.1. Synthesis and Function
The wide distribution of lectins in all tissues of plants and their ubiquitous presence in the
plant kingdom suggest important roles for these proteins. One possible physiological func‐
tion that has emerged is the defensive role of these carbohydrate-binding proteins against
phytopathogenic microorganisms, phytophagous insects and plant-eating animals [102,
107]. Indeed it has been shown that plant lectins possess cytotoxic, fungitoxic, anti-insect
and anti-nematode properties either in vitro or in vivo and are toxic to higher animals[63,
81, 104]. One of the most important features of plant lectins, compatible with the proposed
defensive function, is the remarkably high resistance to proteolysis and stability over a large
range of pH, even when they are out of their natural environment [103].
1.5.2. Anti-nutritional properties
Some of these were found to be toxic or antinutritional for man and animals. In general,
nausea, bloating, vomiting and diarrhoea characterize the oral acute toxicity of lectins on
humans exposed to them.
In experimental animals fed on diets containing plant lectins the evident symptoms are loss
of appetite, decreased body weight and eventually death [84, 108].
As most lectins are not degraded during their passage through the digestive tract they are
able to bind the epithelial cells which express carbohydrate moieties recognised by them.
This event is undoubtedly the second one in importance for determining the toxicity of oral‐
ly fed lectins. Indeed, lectins which are not bound by the mucosa usually induce little or no
harmful antinutritive effect for the consumers [88]. Once bound to the digestive tract, the
lectin can cause dramatic changes in the cellular morphology and metabolism of the stom‐
ach and/ or small intestine and activate a cascade of signals which alters the intermediary
metabolism. Thus, lectins may induce changes in some, or all, of the digestive, absorptive,
protective or secretory functions of the whole digestive system and affect cellular prolifera‐
tion and turnover. In 1960, Jaffe´ suggested that the toxic effects of ingested lectins were due
to their ability to combine with specific receptor sites of the cells lining the small intestine
and to cause a non-specific interference with absorption and nutrient utilisation [50].
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